Cellectar Biosciences, Inc. (CLRB) by event type
CLRB moves most on coverage initiations — a median of -1.50% at 30 minutes across 28 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the CLRB overview →
How CLRB reacts across 2 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Coverage initiations 2,178 of 2,283 | 28 | -1.50% | 25% | -2.75% |
| Rating reiterations 2,999 of 3,522 | 10 | -0.23% | 40% | +0.37% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 3 further classes were observed with fewer than 10 measured events and are not published.
That’s how CLRB usually reacts — get an email when it moves on news →Every name measured for these event types: Coverage initiations → · Rating reiterations → · CLRB overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Qiagen N.V. Common Shares (QGEN) | 266 | +0.05% | 53% |
| 22nd Century Group, Inc (XXII) | 266 | -1.87% | 30% |
| EVOTEC AG S/ADR (EVTCY) | 265 | 0.00% | 17% |
| MiMedx Group, Inc (MDXG) | 265 | +0.14% | 57% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.